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Background: Both genetic and epigenetic alterations have been reported to act as driving forces of tumorigenesis
in colorectal cancer (CRC), but a growing body of evidence suggests that intestinal microbiota may be an
aetiological factor in the initiation and progression of CRC. Recently, the “driver-passenger” model for CRC has
connected these different factors, but little has been done to characterize the CRC gut microbiome.
Findings: Building on the driver-passenger model, we used 454 pyrosequencing of bacterial 16S rRNA genes
associated with 10 normal, 10 adenoma, and 8 tumor biopsy samples, and found 7 potential driver bacterial genera
and 12 potential passenger bacterial genera (7 being pro-inflammatory and 5 anti-inflammatory). Further analysis
also showed certain co-expression patterns among different clusters of bacteria that may potentially be related
to the promotion or progression of gut cancers.
Conclusions: The present findings provide preliminary experimental evidence supporting the proposition of
bacterial “driver-passenger model” for CRC, and identified potentially novel microbial agents that may be
connected to risk of CRC in a Han Chinese population.
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Colorectal cancer (CRC) has long been considered as
malignant cell proliferation caused by accumulated ge-
netic and epigenetic mutations [1,2], but increasing evi-
dence suggests that the composition of the human
intestinal microbiome may offer novel insights into the
aetiology of CRC [3]. If correct, certain intestinal bacter-
ial agents may be significant factors that contribute to
the accumulated mutations that often manifest during
cancer cell differentiation and development in the gut.
From this perspective, Tjalsma et al. proposed a bacterial
driver-passenger model to explain the involvement of mi-
crobial agents in the origin and proliferation of CRC. Under
this model, driver and passenger bacteria each play distinct
roles in eliciting epithelial phenotype transformation of* Correspondence: gqkj003@sina.com; zhangzhigang@mail.kiz.ac.cn
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unless otherwise stated.tissue from normal states, to hyperplasia, and adenoma to
carcinoma [4]. Building on this model, we attempted to
identify potential driver and passenger bacteria that may be
associated with CRC in a Han Chinese population via
454-pyrosequencing analysis of bacterial 16S rRNA genes.Methods
We analyzed a total of 28 location-matched biopsy sam-
ples, including previously gathered normal (n = 10) [5],
and tumor tissues (n = 8) [6], as well as newly sampled
adenoma tissues (n = 10), with each sample being taken
from one individual subject. All patients and healthy con-
trols were of independent genetic background and of Han
Chinese origin, living in Kunming, Yunnan Province,
China. Written informed consent was obtained from all
participants prior to their inclusion in the study. All proto-
cols and procedures of this study were approved by the
Medical Ethics Board of the First People’s Hospital of
Yunnan Province of China, and carried out in accordance
to all relevant provincial, national and international
guidelines.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 16S rRNA gene surveys reveal hierarchical partitioning of
human normal tissue, adenoma tissue and tumor tissue-associated
microbiomes. Bacterial communities were clustered using partial
least squares-discriminant analysis (PLS-DA). Each point corresponds
to a sample colored to indicate tumor, adenoma or normal status.
The normal biopsy samples are colored by green, the adenomas by
red, and the tumors by blue.
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previous studies, which each detailed their respective
methods [5,6]. For the adenoma samples, following
extraction of genomic DNA , the V1-V2 region of the
16S ribosomal RNA (rRNA) gene was amplified via PCR
and then subjected to 454 pyrosequencing analysis, as
described previously [5,6]. Sequencing reads were quality
filtered, OTU clustered (97% sequence identity, equal to
bacterial species level), then ChimeraSlayer filtered and
further analyzed using the QIIME pipeline [7] and RDP-
classifier [8]. OTUs found in ≥20% samples were retained
for the further analysis. PLS-DA plotting of samples based
on microbiota analysis was performed using METAGEN-
assist, a comprehensive web server software used in com-
parative metagenomics [9].
Co-occurring network analysis using the Spearman rank
correlation was conducted using Hmisc 3.9-3 (Harrell,
Vanderbilt University School of Medicine, Nashville, TN,
USA) within the R software package, using the relative
abundance of different types of bacterial genera. Statistical
P-values were corrected using the FDR method in the
p.adjust within the R package. Each co-occurring pair had
an absolute Spearman rank correlation above 0.50, with
an FDR-corrected significance level under 0.05. The
results were transformed into links between two bacterial
taxa in the co-occurrence network. Co-occurring
networks were visualized using Cytoscape 2.8.2 [10].
All statistical analyses were performed using SigmaPlot
12.0 (Systat Software, Inc.) or relevant programs within
the R software package. General characteristics were
expressed as mean or median. Multiple samples compari-
sons were performed using one-way analysis of variance
(ANOVA) (parametric) or Kruskal-Wallis one-way ANOVA
on ranks (non-parametric).
Results
After filtering raw data with our set of criteria [6], we
obtained a dataset consisting of a total of 100,276 high
quality 16S rRNA gene sequences, with an average of
3,581 ± 408 (S.E.) (n = 28) sequences per sample. Within
the dataset we identified a total of 767 OTUs, based on
97% sequence similarity (equal to bacterial species level),
with an average of 290 ± 16 (n = 28) OTUs per sample.
Using the estimation of Good’s Coverage [11,12] showed
that 95.20 ± 0.70% of the total found species were repre-
sented in any given sample, ensuring completeness and
accuracy of data used for further analyses.
PLS-DA analysis illustrated a distinct structural segre-
gation for all 28 samples that appears to be primarily
related to health/disease conditions rather than other
factors (e.g., inter-individual differences) (Figure 1). The
driver-passenger model proposed by Tjalsma [4] holds
that CRC-associated bacterial drivers can be defined as
intestinal bacteria with procarcinogenic features thatmay potentially initiate CRC development, while bacter-
ial passengers are gut bacteria known to exist within
the gut microbiome of patients with advanced-CRC,
which should have a competitive advantage in the tumor
microenvironment, allowing them to outcompete bacter-
ial drivers of CRC. Using these definitions, we identified
7 bacterial genera as potential driver bacteria (Figure 2A)
and 12 bacterial genera as potential passenger bacteria
(Figure 2B and C). Since the identified passenger bacteria
may influence either the suppression or promotion of
tumor development [4], we further examine these bacteria
and identified 7 of the 12 passenger bacterial genera as
potential pro-inflammatory agents with low abundance in
normal tissue (Figure 2C), and the remaining 5 genera as
potential anti-inflammatory agents with high abundance
in both normal and tumor tissues (Figure 2B).
Presuming that bacteria play functional roles in the
progression of CRC, then within the CRC microbiome,
bacteria with specific functions should be either co-
existed or co-occurred. Correlation analysis of the 19
bacterial taxa (described in Figure 2A-C) showed that
bacterial taxa with the same defined role were clustered
into groups with positive correlation of each other
(Figure 2D). These positive associations partially support
the “driver and passenger bacteria” notion. We also found
that the driver bacterial cluster was significantly and
positively correlated to the pro-inflammatory passenger
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Figure 2 Identification of potential driver and passenger bacteria associated with CRC and their co-occurrences. Unclassified taxa
were represented by star. *FDR-corrected P < 0.05. (A) Potential driver bacteria whose relative abundances in adenoma tissues were significantly
higher than in normal and tumor tissues; (B) Potential anti-inflammatory passenger bacteria whose relative abundances in adenoma tissues were
significantly lower than in normal and tumor tissues; (C) Potential pro-inflammatory passenger bacteria whose relative abundances in normal
tissues were significantly lower than in tumor or/and adenoma tissues; (D) Correlation relationships among three types of CRC bacteria as described
(A)-(C). Each co-occurring pair has an absolute Spearman rank correlation above 0.50 with an FDR-corrected significance level under 0.05. Node labels are
corresponding to bacterial taxa. Edges are colored by positive or negative correlations. Driver bacterial cluster was colored by green, anti-inflammatory
passenger bacterial cluster by blue and pro-inflammatory passenger bacterial cluster by yellow.
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http://www.gutpathogens.com/content/6/1/26bacterial cluster (Figure 2D), suggesting that the presence
of driver bacteria may drive the colonization of tumor-
foraging opportunistic pathogens (e.g., Streptococcus spp.).
Conversely, the anti-inflammatory passenger bacterial cluster
was significantly and negatively correlated with the driver
bacterial cluster (Figure 2D), implying that anti-inflammatory
passenger bacteria may primarily be restricted to the early
phases of carcinogenesis.
Discussion
Collectively, our results suggest a potentially dynamic
and previously unknown interaction among intestinal
mucosal bacteria that may markedly impact the occur-
rence or suppression of tumor development within the
gut. Consistent with the earlier findings of Tjalsma et al.
[4], our analysis identified members of Enterobacteria-
ceae (Figure 2A) as potential bacterial drivers, and Strep-
tococcaceae (Figure 2C) as possible pro-inflammatory
passenger bacteria. This finding was not unexpected,since earlier reports considered both Escherichia coli
(Enterobacteriaceae) and Streptococcus gallolyticus (Strep-
tococcaceae) as protagonists of tumor development due to
the correlation of their presence and increased risks of
CRC [3]. Despite these general similarities, there were
some marked differences among our studied Han Chinese
population. Previously, the gut enterotoxigenic Bacteroides
fragilis and Fusobacterium spp. were respectively found to
act as driver bacteria and pro-inflammatory passenger
bacteria [3,4] but in our present study, neither appeared in
significant abundance differences across any of the sam-
pled tissues. Heterogeneity across the gut microbiome
between different populations may explain this difference,
with those two bacterial taxa being potentially and weakly
linked to CRC among a Chinese population.
The differences between our studied population and
those found in previous is not unexpected, as numerous
reports have found evidence suggesting that the CRC
gut microbiomes vary considerably by population, age or
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http://www.gutpathogens.com/content/6/1/26biogeographic position. For instance, there are signifi-
cant regional variations in CRC microbiota, with the
well-known Fusobacterium spp. being more abundant in
colon tumors from Spanish populations as compared to
those in the United States or Vietnam [13]. There are
also age-dependent divergences in the CRC microbiomes
of younger and older patients [14]. Earlier studies also
ignored variations in microbiome composition based
sample locations, which can vary considerably, even
among patients. For example, there are significant differ-
ences in microbial structure and community compos-
ition between normal fecal and mucosal samples [15],
especially among CRC patients [16]. Similar variations
are also found between samples obtained at different
positions along the normal intestinal tract [5]. Diffe-
rences in analysis, methodology (e.g., phylogeny, cultu-
ring, and metagenomics), and sample size can also lead
to markedly different findings [17].
Aside from the observed similarities and differences
between our study and the previous reports [13,16,18-22],
we also identified several new potential driver bacteria
(e.g., unclassified Pseudomonadaceae and Neissenaceae)
(Figure 2A) and pro-inflammatory passenger bacteria (e.g.,
Staphylococcus and Veillonella) (Figure 2C). Previous
reports found that Pseudomonadaceae were markedly
increased in the stools of patients with end-stage renal dis-
ease [23], while Staphylococcus was considerably related to
advanced-stage colon cancer [24] and Veillonella to gut
disorders among patients with minimal hepatic encepha-
lopathy [25]. Together, these findings suggest that the
novel bacterial agents we identified in this study may be
related to CRC progression. Further study of these novel
genera may help fully elucidate their function within the
gut microbiome, as well as their potential associations
with CRC. Curiously, we also noted a discrepancy in
the distribution of certain anti-inflammatory bacteria
(Figure 2B) enriched in normal intestinal mucosa [5] but
decreased in CRC patients [26]. This discrepancy suggests
that the anti-inflammatory bacteria we observed may func-
tion in some manner that delays the progression of CRC,
potentially by preserving intestinal niches or producing
compounds that exhibit anti-carcinogenic activities [4].
Unfortunately, the precise effect of these bacteria on the
tumor microenvironment remains unclear, but such anti-
inflammatory bacteria may prove viable targets for
researches into gut disorders or CRC therapeutics.
Taken on the whole, our results—especially those
which differ from those in previous reports—serve as
the reminders of the difficulty inherent in examining the
relationship between gut disorders, gut microbiome
composition and structure, and larger genetic or envir-
onmental factors. One advantage of the driver-passenger
model is that it combines several of these factors into a
more comprehensive framework that helps explain theetiology and underlying mechanisms behind gut dis-
orders like CRC. However, the observed heterogeneity of
the gut microbiome due to different populations, disease
status, or sample locations highlights the need for alter-
native approaches that can more adequately characterize
changes to the microbiome that often accompany—or
potentially underlie—gut disorders like CRC. More ef-
fective models, such as the driver-passenger model, may
be able to better explain the correlations between
changes in the gut microbiome composition and struc-
ture, thereby leading to improved diagnostics.Conclusion
In conclusion, our results largely support the proposition
of the bacterial driver-passenger model for CRC proposed
by Tjalsma et al. [4]. The potential driver and passenger
bacteria we identified in the present study also offer fur-
ther evidence into exploring the relationship between
changes in the gut microbiome composition and structure
and CRC. Further replication with a larger sample size will
likely help develop a more generally applicable pattern of
CRC microbiome variations in Chinese populations, and
provide foundational evidence needed to fully elucidate
the observed heterogeneity between different populations
with CRC.
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